These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 18173856

  • 1. Carbonic anhydrase IX in oligodendroglial brain tumors.
    Järvelä S, Parkkila S, Bragge H, Kähkönen M, Parkkila AK, Soini Y, Pastorekova S, Pastorek J, Haapasalo H.
    BMC Cancer; 2008 Jan 04; 8():1. PubMed ID: 18173856
    [Abstract] [Full Text] [Related]

  • 2. Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis.
    Haapasalo JA, Nordfors KM, Hilvo M, Rantala IJ, Soini Y, Parkkila AK, Pastoreková S, Pastorek J, Parkkila SM, Haapasalo HK.
    Clin Cancer Res; 2006 Jan 15; 12(2):473-7. PubMed ID: 16428489
    [Abstract] [Full Text] [Related]

  • 3. The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis.
    Colpaert CG, Vermeulen PB, Fox SB, Harris AL, Dirix LY, Van Marck EA.
    Breast Cancer Res Treat; 2003 Sep 15; 81(2):137-47. PubMed ID: 14572156
    [Abstract] [Full Text] [Related]

  • 4. Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use.
    Pastorek J, Pastorekova S.
    Semin Cancer Biol; 2015 Apr 15; 31():52-64. PubMed ID: 25117006
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue.
    Kim SJ, Shin HJ, Jung KY, Baek SK, Shin BK, Choi J, Kim BS, Shin SW, Kim YH, Kim JS, Oosterwijk E.
    Jpn J Clin Oncol; 2007 Nov 15; 37(11):812-9. PubMed ID: 18057013
    [Abstract] [Full Text] [Related]

  • 6. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer.
    Hussain SA, Ganesan R, Reynolds G, Gross L, Stevens A, Pastorek J, Murray PG, Perunovic B, Anwar MS, Billingham L, James ND, Spooner D, Poole CJ, Rea DW, Palmer DH.
    Br J Cancer; 2007 Jan 15; 96(1):104-9. PubMed ID: 17213826
    [Abstract] [Full Text] [Related]

  • 7. Carbonic anhydrase IX, a marker of hypoxia: correlation with clinical outcome in transitional cell carcinoma of the bladder.
    Hussain SA, Palmer DH, Ganesan R, Hiller L, Gregory J, Murray PG, Pastorek J, Young L, James ND.
    Oncol Rep; 2004 May 15; 11(5):1005-10. PubMed ID: 15069539
    [Abstract] [Full Text] [Related]

  • 8. Carbonic anhydrase IX as a marker for poor prognosis in soft tissue sarcoma.
    Måseide K, Kandel RA, Bell RS, Catton CN, O'Sullivan B, Wunder JS, Pintilie M, Hedley D, Hill RP.
    Clin Cancer Res; 2004 Jul 01; 10(13):4464-71. PubMed ID: 15240538
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas.
    Driessen A, Landuyt W, Pastorekova S, Moons J, Goethals L, Haustermans K, Nafteux P, Penninckx F, Geboes K, Lerut T, Ectors N.
    Ann Surg; 2006 Mar 01; 243(3):334-40. PubMed ID: 16495697
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
    Swinson DE, Jones JL, Richardson D, Wykoff C, Turley H, Pastorek J, Taub N, Harris AL, O'Byrne KJ.
    J Clin Oncol; 2003 Feb 01; 21(3):473-82. PubMed ID: 12560438
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells.
    Vordermark D, Kaffer A, Riedl S, Katzer A, Flentje M.
    Int J Radiat Oncol Biol Phys; 2005 Mar 15; 61(4):1197-207. PubMed ID: 15752902
    [Abstract] [Full Text] [Related]

  • 17. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
    Puccetti L, Fasolis G, Cecchi A, Winum JY, Gamberi A, Montero JL, Scozzafava A, Supuran CT.
    Bioorg Med Chem Lett; 2005 May 02; 15(9):2359-64. PubMed ID: 15837325
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.